Asset Allocation

As of April 30, 2026.
Type % Net
Cash 0.37%
Stock 69.67%
Bond 6.32%
Convertible 16.97%
Preferred 4.38%
Other 2.28%
View Asset Allocation
Start Trial

Market Capitalization

As of April 30, 2026
Large 66.44%
Mid 17.17%
Small 16.39%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 79.10%    % Emerging Markets: 0.32%    % Unidentified Markets: 20.58%

Americas 70.10%
69.87%
Canada 2.00%
United States 67.87%
0.23%
Mexico 0.01%
As of April 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 6.77%
United Kingdom 2.80%
3.97%
Finland 0.00%
France 0.46%
Germany 0.28%
Ireland 1.45%
Italy 0.21%
Netherlands 0.57%
Spain 0.01%
Switzerland 0.99%
0.00%
0.00%
Greater Asia 2.55%
Japan 0.23%
0.00%
2.32%
South Korea 1.43%
Taiwan 0.89%
0.00%
Unidentified Region 20.58%

Bond Credit Quality Exposure

AAA 0.00%
AA 0.07%
A 0.16%
BBB 18.83%
BB 4.07%
B 0.93%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 75.94%
Short Term 0.00%
As of April 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
40.63%
Materials
1.24%
Consumer Discretionary
6.69%
Financials
12.99%
Real Estate
19.72%
Sensitive
28.71%
Communication Services
2.76%
Energy
7.36%
Industrials
8.83%
Information Technology
9.76%
Defensive
24.99%
Consumer Staples
8.99%
Health Care
11.92%
Utilities
4.08%
Not Classified
5.67%
Non Classified Equity
4.25%
Not Classified - Non Equity
1.42%
As of April 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of April 30, 2026
Type % Net
Government 2.99%
Corporate 79.65%
Securitized 0.00%
Municipal 0.00%
Other 17.36%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.99%
Less than 1 Year
2.99%
Intermediate
0.17%
1 to 3 Years
0.10%
3 to 5 Years
0.07%
5 to 10 Years
0.00%
Long Term
15.92%
10 to 20 Years
0.00%
20 to 30 Years
6.95%
Over 30 Years
8.98%
Other
80.92%
As of April 30, 2026
View Bond Maturity Exposure
Start Trial